直肠癌新辅助治疗期间及之后运动训练(EXERT试验):随机对照试验研究方案
EXERT试验为单中心、前瞻性、双臂II期随机对照试验,计划纳入60例拟接受长程新辅助放化疗后行全直肠系膜切除术的直肠癌患者,随机分为运动训练组与常规护理组,主要终点为新辅助放化疗后心肺适能(VO2 peak)。
要点
- 运动训练组在新辅助放化疗期间每周完成3次监督下高强度间歇训练,放化疗后至手术前每周≥150分钟无监督中高强度持续运动训练。
- 常规护理组被要求不增加基线运动量。
- 主要终点为新辅助放化疗后时间点通过分级运动试验评估的VO2 peak。
核心结论
- 若EXERT试验初步结果阳性,则需进一步研究确认运动是否可作为维持生活质量、管理副作用和/或改善直肠癌患者治疗结局的创新治疗手段。
研究设计与样本
- EXERT为单中心、前瞻性、双臂II期随机对照试验,旨在检验运动训练在该临床场景中的初步疗效并进一步评估其可行性与安全性。
- 计划纳入60例拟接受长程新辅助放化疗后行全直肠系膜切除术的直肠癌患者,随机分配至运动训练组或常规护理组。
- 评估在新辅助放化疗前、新辅助放化疗后及手术前完成。
关键数值与推荐
- 运动训练组在新辅助放化疗期间每周完成3次监督下高强度间歇训练,新辅助放化疗后至手术前每周≥150分钟无监督中高强度持续运动训练。
- 常规护理组被要求不增加基线运动量。
- 主要终点为新辅助放化疗后时间点通过分级运动试验评估的心肺适能(VO2 peak)。
- 次要终点包括采用Senior's Fitness Test评估的功能适能、采用欧洲癌症研究与治疗组织量表评估的生活质量、采用M.D. Anderson症状量表评估的症状管理。
- 探索性临床终点包括治疗毒性、治疗完成、治疗反应及手术并发症。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Standard treatment for locally advanced rectal cancer includes 5-6 weeks of neoadjuvant chemoradiotherapy (NACRT) followed by total mesorectal excision 6-8 weeks later. NACRT improves local disease control and surgical outcomes but also causes side effects including fatigue, diarrhea, hand-foot syndrome, and physical deconditioning that may impede quality of life (QoL), treatment completion, treatment response, and long-term prognosis. Interventions to improve treatment outcomes and manage side effects that are safe, tolerable and low-cost are highly desirable. Exercise has been shown to improve some of these outcomes in other cancer patient groups but no study to date has examined the potential benefits (and harms) of exercise training during and after NACRT for rectal cancer. METHODS/DESIGN: The Exercise During and After Neoadjuvant Rectal Cancer Treatment (EXERT) trial is a single-center, prospective, two-armed, phase II randomized controlled trial designed to test the preliminary efficacy of exercise training in this clinical setting and to further evaluate its feasibility and safety. Participants will be 60 rectal cancer patients scheduled to receive long-course NACRT followed by total mesorectal excision. Participants will be randomly assigned to exercise training or usual care. Participants in the exercise training group will be asked to complete three supervised, high-intensity interval training sessions/week during NACRT and ≥ 150 min/week of unsupervised, moderate-to-vigorous-intensity, continuous exercise training after NACRT prior to surgery. Participants in the usual care group will be asked not to increase their exercise from baseline. Assessments will be completed pre NACRT, post NACRT, and pre surgery. The primary endpoint will be cardiorespiratory fitness (VO2 peak) at the post-NACRT time point assessed by a graded exercise test. Secondary endpoints will include functional fitness assessed by the Senior's Fitness Test, QoL assessed by the European Organisation of Research and Treatment of Cancer, and symptom management assessed by the M.D. Anderson Symptom Inventory. Exploratory clinical endpoints will include treatment toxicities, treatment completion, treatment response, and surgical complications. DISCUSSION: If the preliminary findings of EXERT are positive, additional research will be warranted to confirm whether exercise is an innovative treatment to maintain QoL, manage side effects, and/or improve treatment outcomes in rectal cancer patients. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03082495 . Registered on 9 February, 2017.
引用
- Morielli AR, Usmani N, Boulé NG, et al. Exercise during and after neoadjuvant rectal cancer treatment (the EXERT trial): study protocol for a randomized controlled trial. Trials. 2018. PMID: 29329555. doi:10.1186/s13063-017-2398-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。